Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

In Brief: Preamendment Class III device reg

This article was originally published in The Gray Sheet

Executive Summary

Preamendment Class III device reg: FDA publishes proposal June 18 to retain in Class III three preamendment Class III products -- lung water monitors, powered vaginal muscle stimulators for therapeutic use, and stair-climbing wheelchairs. Written comments are due Sept. 16. Summaries of and citations to safety and effectiveness data on the devices were due at FDA in August 1996. Based on "the lack of safety and effectiveness data submitted in response" to the call for data, FDA concludes that insufficient information exists to reclassify the products...
Advertisement
Advertisement
UsernamePublicRestriction

Register

MT008281

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel